Paper·2024·Research article
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Asks which blood marker predicts who responds to leucovorin, and points to the binding autoantibody.
New to this?
Start with the question you came with.
Every topic gathers its plain-language guide, handouts, videos, papers and courses in one place.
Book·2025·For families and clinicians
Exploring the Role of Folate in Autism and Neurodevelopmental Disorders

The story of folate in autism, told through families’ experiences, with evaluation strategies, treatment practice and the questions clinicians and caregivers ask most.
You complete your purchase on the retailer’s site, and this site takes no payment. The book is published and sold by Metabolic Learning Resource, founded by Dr. Frye.
Before you buy
Parents and caregivers who have heard about folate or and want the whole story before they talk with their child’s doctor.
Clinicians who want a guide to leucovorin from the investigator who led the first double-blind, placebo-controlled trial of it in autism.
Leucovorin is not an “autism pill”
It is a prescription medicine that needs the right patient, dose and formulation. The book is education, not a treatment plan.
In the publisher’s own description, the book brings together families’ stories and clinical practice.
The story of folate in autism is told through the experiences of families.
Ways to evaluate a child, set out for clinicians and caregivers.
A guide to leucovorin in practice, for clinicians and patients.
Answers to the questions clinicians and caregivers ask most.

About the author
Dr. Frye is a pediatric neurologist, and the foundation’s Chief Scientific Officer and cofounder. He has studied leucovorin in autism for about two decades, and led the first double-blind, placebo-controlled trial of it in 2018. His research has been supported in the past by the National Institutes of Health, the Department of Defense and Autism Speaks.
Landmark papers on cerebral folate deficiency and leucovorin, chosen from the 11 in the library on this subject.
Paper·2024·Research article
Asks which blood marker predicts who responds to leucovorin, and points to the binding autoantibody.
Paper·2021·Systematic review
Paper·2018·Clinical trial
The first double-blind, placebo-controlled trial of leucovorin in autism. Over 12 weeks, 23 children on leucovorin improved in verbal communication compared with 25 on placebo.
Paper·2013·Research article
In 93 children with autism, about three in four tested positive for folate receptor autoantibodies. An open-label study, with a waitlist comparison group.
Related course
Course·45 min·6 chapters
No. The book explains the science and how clinicians approach it, so that you can have a better conversation with a clinician. It does not replace one.
A Spanish edition is in production. It is not on sale yet. ADTF Weekly will say when it is.
The book is published and sold by Metabolic Learning Resource, founded by Dr. Frye. You pay the retailer you choose, and this site takes no payment. To support the foundation’s research directly, give to the foundation.
This book is not medical advice
It is for education and is not a substitute for a consultation with a qualified clinician. Leucovorin is a prescription medicine; decisions about it belong with your child’s doctor.
ADTF Weekly
A short video from Dr. Frye on one new paper, what it means for families, and what the foundation is working on. Free, and you can leave at any time.